Adimmune Corp (4142) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Adimmune Corp (4142:TWSE), powered by AI.

Current Price
$17.50
Sector
Healthcare
What is the Adimmune Corp stock price forecast?

Adimmune Corp is currently trading at $17.50. View real-time AI analysis on Alpha Lenz.

What is Adimmune Corp insider trading activity?

View the latest insider trading data for Adimmune Corp on Alpha Lenz.

What is Adimmune Corp's P/E ratio?

View Adimmune Corp's valuation metrics on Alpha Lenz.

Adimmune Corp

TWSE · 4142
NT$17.50+0.05(+0.29%)
Ask about Adimmune Corp's future dividend policy...
Alpha Chat Insight

Adimmune Corp's ROE is -4.7%. Explore profitability and growth together.

Ask for details

Company Overview

Adimmune Corp is a biotechnology company focusing on the research, production, and distribution of vaccines. Established as a significant player within the pharmaceutical industry, its primary function is to develop vaccines that contribute to public health by preventing infectious diseases. The company is involved in producing seasonal influenza vaccines and is active in research for innovative vaccine solutions to tackle emerging health threats. Additionally, Adimmune Corp extends its operations to contract manufacturing services for other pharmaceutical companies, utilizing its advanced production facilities. The corporation plays a crucial role in the healthcare sector by ensuring the availability of critical vaccines, thus supporting global health initiatives. With a commitment to maintaining high-quality standards and deploying cutting-edge technology, Adimmune Corp is essential to the global supply chain for vaccines, thereby contributing to the mitigation of disease spread and the promotion of public health on an international scale.

CEOMr. Chi-Hsien Chan
SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$1.40BRevenue
0.00Shares Out
0Employees

Margins

20.58%Gross
-3.26%EBITDA
-22.94%Operating
-23.53%Pre-Tax
-23.53%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-14.62%Rev 3Yr
-5.60%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-3.96%ROA
-4.71%ROE
-3.58%ROIC

Financial Health

NT$2.19BCash & Cash Equivalents
NT$954.43MNet Debt
62.18%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Adimmune Corp (ticker: 4142) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 17.5 with a P/E ratio of -x and P/B of -x.

ROE is -4.71% and operating margin is -22.94%. Annual revenue is $1.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Adimmune Corp (4142) Stock Forecast 2026 $17.50 — Price, Financials & Analyst Targets | Alpha Lenz